India’s Dearth of Drug R&D Investment Creates Innovation Bottleneck
This article was originally published in PharmAsia News
Executive Summary
BOSTON - India faces a lacuna in research and development funding, with lags in government investment and venture capital activity that are creating roadblocks to accelerating the country's growth in the pharmaceutical sector, experts said at the USA-India Chamber of Commerce BioPharma & Healthcare Summit in Boston